In juvenile hemangioma, a C482R mutation in VEGFR-2 results in the amplification of VEGF/VEGFR-2 signaling and an increase in angiogenesis, while in neoplasms such as melanoma, VEGF upregulation is associated with disease progression [30]. Here, VEGFA is linked to melanoma.